Knockdown of FBXL19-AS1 exerts a protective effect on Human retinal endothelial cells treated with high glucose by targeting miR-200c-3p.
OBJECTIVE Proliferative diabetic retinopathy (PDR) is a leading cause of blindness. FBXL19-AS1 is highly expressed in the retinas of PDR patients. This study aims to investigate its diagnostic value in PDR and its potential regulatory mechanisms. METHODS A total of 102 patients with PDR were enrolled. RT-qPCR was use...